Phase II study of ixabepilone in patients with metastatic breast cancer and a prospective evaluation of its effects on the ultrastructure of neurons

Study Status

Open to Enrollment

Study Description

This study will look at neurological changes in patients with metastatic breast cancer who receive ixabepilone chemotherapy.

Disease Status and/or Stage

Metastatic Breast Cancer


Weill Cornell Medical College; Bristol-Myers Squibb

Key Eligibility

  • Age 18 and over
  • Stage IV breast cancer
  • Life expectancy greater than 3 months
  • Additional eligibility criteria will be discussed with you when you contact the study team

Principal Investigator

Linda Vahdat, MD


Healthy Volunteers


As a healthy volunteer in a clinical trial you may make a significant contribution to the discovery of medical knowledge and new treatments that could impact people around the world.
Click here for studies seeking healthy volunteers.

Contact Us

For general inquiries, or if you need assistance finding a study, please contact:

Erica Bersin
Tel: (646) 962-8232
[email protected]

Top of page